Ajanta Pharma
Ajanta Pharma Share Price Chart
Ajanta Pharma last traded at ₹3,399.50 (2026-10-13). Over the past month the stock moved -3.0%, three months the stock moved +9.8%, year the stock moved +33.5%. Its closing range over 52 weeks is ₹2,413.40 – ₹3,725.00, with the latest close 8.7% below the high.
Closing prices up to 2026-10-13.
About Ajanta Pharma
Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages.(Source : 202003-01 Annual Report Page No:70).
Geography-wise Business split:[1] India: 30% US: 29% Asia: 22% Africa: 16% Africa: 3%
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Ajanta Pharma reported sales of ₹1,626.00 crore (+24.8%) and net profit of ₹334.00 crore (+31.0%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 1,626 | 424.00 | 26.00 | 334.00 | 26.75 |
| Mar 2026 | 1,422 | 333.00 | 23.00 | 267.00 | 21.35 |
| Dec 2025 | 1,375 | 382.00 | 28.00 | 274.00 | 21.91 |
| Sep 2025 | 1,354 | 328.00 | 24.00 | 260.00 | 20.83 |
| Jun 2025 | 1,303 | 351.00 | 27.00 | 255.00 | 20.44 |
| Mar 2025 | 1,170 | 297.00 | 25.00 | 225.00 | 18.03 |
| Dec 2024 | 1,146 | 321.00 | 28.00 | 233.00 | 18.64 |
| Sep 2024 | 1,187 | 311.00 | 26.00 | 216.00 | 17.33 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +15.5% | +3.7% | +11.0% | +13.8% | +14.1% | +20.0% | +21.5% | +24.8% |
| Operating profit growth | +6.9% | +2.2% | +6.8% | +6.4% | +5.5% | +19.0% | +12.1% | +20.8% |
| Net profit growth | +10.8% | +11.0% | +10.8% | +3.7% | +20.4% | +17.6% | +18.7% | +31.0% |
| EPS growth | +13.7% | +13.7% | +14.0% | +3.9% | +20.2% | +17.5% | +18.4% | +30.9% |
| OPM % | 26.0% | 28.0% | 25.0% | 27.0% | 24.0% | 28.0% | 23.0% | 26.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Ajanta Pharma reported sales of ₹5,453.00 crore (+17.3%) and net profit of ₹1,056.00 crore (+14.8%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 5,453 | 1,395 | 26.00 | 1,056 | 84.52 |
| Mar 2025 | 4,648 | 1,269 | 27.00 | 920.00 | 73.68 |
| Mar 2024 | 4,209 | 1,172 | 28.00 | 816.00 | 63.70 |
| Mar 2023 | 3,743 | 808.00 | 22.00 | 588.00 | 45.89 |
| Mar 2022 | 3,341 | 933.00 | 28.00 | 713.00 | 55.63 |
| Mar 2021 | 2,890 | 1,001 | 35.00 | 654.00 | 50.38 |
| Mar 2020 | 2,588 | 683.00 | 26.00 | 468.00 | 35.73 |
| Mar 2019 | 2,055 | 567.00 | 28.00 | 387.00 | 29.56 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -3.3% | +25.9% | +11.7% | +15.6% | +12.0% | +12.4% | +10.4% | +17.3% |
| Operating profit growth | -13.8% | +20.5% | +46.6% | -6.8% | -13.4% | +45.0% | +8.3% | +9.9% |
| Net profit growth | -17.5% | +20.9% | +39.7% | +9.0% | -17.5% | +38.8% | +12.7% | +14.8% |
| EPS growth | -16.7% | +20.9% | +41.0% | +10.4% | -17.5% | +38.8% | +15.7% | +14.7% |
| OPM % | 28.0% | 26.0% | 35.0% | 28.0% | 22.0% | 28.0% | 27.0% | 26.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Ajanta Pharma.
Get Free AI Stock Analysis FREE →Latest News
-
Ajanta Pharma promoter Aayush Agrawal pledges 9.2 lakh shares - scanx.trade
-
Ajanta Pharma among 5 midcap stocks to hit 52-week highs & surge up to 18% in a month - The Economic Times
-
Ajanta Pharma among 5 midcap stocks to hit 52-week highs & surge up to 18% in a month - The Economic Times
-
Ajanta Pharma Ltd soars 0.37%, rises for fifth straight session - Business Standard
-
Ajanta Pharma Ltd soars 0.37%, rises for fifth straight session - Business Standard
-
Ajanta Pharma Q1 PAT Rises 31% to Rs 334 Cr
-
Ajanta Pharma Q1 PAT Rises 31% to Rs 334 Cr
-
Cipla, Ajanta Pharma to Alkem Laboratories: Pharma stocks rise amid weak trends on Dalal Street
-
Ajanta Pharma gets USFDA inspection report for Paithan manufacturing facility; shares trade flat
-
Ajanta Pharma gets USFDA inspection report for Paithan manufacturing facility; shares trade flat
Frequently Asked Questions
What is Ajanta Pharma's current stock price?
Ajanta Pharma shares were last quoted at ₹3,399.50 (-0.3% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Ajanta Pharma?
Ajanta Pharma has a price-to-earnings (P/E) ratio of 39.07 and a price-to-book (P/B) ratio of 9.12. The industry P/E is 53.33.
What is the 52-week high and low of Ajanta Pharma?
The 52-week high of Ajanta Pharma is ₹3,796.95 and the 52-week low is ₹2,335.00.
What is the market cap of Ajanta Pharma?
The market capitalisation of Ajanta Pharma is about ₹44,344.21 crore.
How did Ajanta Pharma perform in its latest quarterly results?
In the latest quarter (Jun 2026), Ajanta Pharma reported sales of ₹1,626.00 crore (+24.8%) and net profit of ₹334.00 crore (+31.0%), compared with the same quarter last year.
Is Ajanta Pharma a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Ajanta Pharma has a 3-year ROE of 25.00%, 3-year profit growth of 24.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Ajanta Pharma?
Promoters hold about 63.48% of Ajanta Pharma.
Which sector does Ajanta Pharma belong to?
Ajanta Pharma belongs to the Pharmaceuticals & Drugs sector.